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Abstract
Purpose This study aimed to assess: (1) oral symptoms of
patients treated for oral or oropharyngeal cancer; (2) how
patients rank the burden of oral symptoms; (3) the impact
of the tumor, the treatment, and oral symptoms on
functional outcome.
Methods Eighty-nine patients treated for oral or oropha-
ryngeal cancer were asked about their oral symptoms
related to mouth opening, dental status, oral sensory
function, tongue mobility, salivary function, and pain. They
were asked to rank these oral symptoms according to the
degree of burden experienced. The Mandibular Function
Impairment Questionnaire (MFIQ) was used to assess
functional outcome. In a multivariate linear regression
analyses, variables related to MFIQ scores (p≤0.10) were
entered as predictors with MFIQ score as the outcome.
Results Lack of saliva (52%), restricted mouth opening
(48%), and restricted tongue mobility (46%) were the
most frequently reported oral symptoms. Lack of saliva
was most frequently (32%) ranked as the most burden-
some oral symptom.
For radiated patients, an inability to wear a dental
prosthesis, a T3 or T4 stage, and a higher age were
predictive of MFIQ scores. For non-radiated patients, a
restricted mouth opening, an inability to wear a dental
prosthesis, restricted tongue mobility, and surgery of the
mandible were predictive of MFIQ scores.
Conclusions Lack of saliva was not only the most
frequently reported oral symptom after treatment for oral
or oropharyngeal cancer, but also the most burdensome.
Functional outcome is strongly influenced by an inability
to wear a dental prosthesis in both radiated and non-
radiated patients.
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Introduction
After oral and oropharyngeal cancer treatment, patients
may report several oral symptoms, such as a restricted
mouth opening, lack of saliva, an inability to wear a
dental prosthesis or lack of retention of the prosthesis,
loss of oral sensory function, and restricted tongue
mobility [1–3]. These oral symptoms can have a negative
influence on functional outcome.
Functional outcome after treatment for oral or oro-
pharyngeal cancer is related to tumor site, tumor size,
and the type of treatment received [4–8]. A study in
patients treated for cancer of the base of the tongue, found
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DOI 10.1007/s00520-010-0952-4that surgery which included the mandible (mandibulec-
tomy or mandibulotomy) reduced functional outcome
significantly more than surgery which did not include the
mandible [5]. In that study, functional outcome was
assessed by eating, speech, and diet (eating in public and
normalcy of diet). Furthermore, reconstruction with free-
tissue transfer results in a significantly worse functional
outcome when compared to direct reconstruction techni-
ques [5, 6, 8]. Finally, a higher T stage (T3 or T4) and a
larger resection size are also associated with a poorer
functional outcome [4–6, 8].
In addition to tumor and treatment characteristics, oral
symptoms may also impede functional outcome. A
restricted mouth opening affects mandibular function,
including chewing, eating, and swallowing, and may also
impede oral hygiene, dental treatment, and oncological
follow-up [9]. Lack of saliva, resulting from radiation-
induced damage to the salivary glands or from removal of
a salivary gland, impedes consolidation of a food bolus
and functional outcome significantly [10, 11]. Lack of
retention and pain may inhibit biting and chewing in
edentulous or partially dentate patients wearing a dental
prosthesis [10]. Clinically, pain in the mouth can also
impede functional outcome.
To study oral symptoms related to oral and oropha-
ryngeal cancer, and their association with functional
outcome, three aims were formulated for this study.
The first was to assess oral symptoms of patients treated
for oral or oropharyngeal cancer. Before treatment of oral
or oropharyngeal cancer, most patients rank being cured
as the most important outcome, followed by living as
long as possible and having no pain. Only a few patients
rank normal swallowing, normal taste, and normal
salivation as important [12, 13]. It is currently unclear
which oral symptoms are most burdensome to patients
after treatment of oral and oropharyngeal cancer. The
second aim was therefore to assess how patients rank the
burden of their oral symptoms. Finally, oral or oropha-
ryngeal cancer and the consequences of treatment can
influence mandibular functioning (Fig. 1). However, it is
unclear which factors have the largest impact on function-
al outcome. The third aim was to analyze the impact of the
tumor, cancer treatment, and oral symptoms on functional
outcome.
Patients and methods
Patients
Patients aged ≥18 years, who were treated for oral or
oropharyngeal cancer at the department of Oral and
Maxillofacial Surgery, Division Oncology, University Med-
ical Center Groningen, the Netherlands, were invited to
participate in this cross-sectional study. Patients were
informed about the study by means of a letter sent 1 week
prior to their regular follow-up appointment. During this
appointment, the physician further informed the patient and
invited them to participate. Assessment was performed after
patients signed a written informed consent.
Included in the study were patients who had
completed their treatment for oral or oropharyngeal
cancer at least 6 months before study assessment.
Treatment consisted of surgery or a combination of
surgery and radiotherapy. Excluded were patients who
did not have sufficient understanding of Dutch to be
interviewed or patients who were physically or mentally
not fit enough to participate. Information regarding the
type and localization of the tumor, TN classification,
and type of treatment (surgery, radiotherapy) was
retrieved from the medical records.
Oral symptoms
Assessment of oral symptoms was performed by one
observer (PMH), who asked whether the patient:
Tumor characteristics 
-  T classification 
-  Location 
-  Type 
Treatment characteristics 
-  Surgery  
-  Radiotherapy 
Oral symptoms 
-  Lack of mobility (tongue, lips, 
mandible) 
-  Pain, lack of sensation (e.g. tongue, 
lips) 
-  Salivary function  
-  Dental status 
1 
2 5
4
3
Mandibular  
functioning 
6 
Fig. 1 Clinical model of factors influencing mandibular functioning.
Within this study, a clinical model of factors influencing mandibular
functioning was hypothesized and analyzed: (1) Tumor characteristics
determine treatment modalities (extent of surgery, dose of radiother-
apy, etc.). (2) Besides anti-tumor effects, treatments also induce
adverse effects, resulting in oral symptoms. (3) These oral symptoms
may result in restrictions in mandibular functioning. (4, 5) However, it
is possible that some tumor characteristics or treatment characteristics
influence mandibular functioning directly without actually resulting in
specific oral symptoms. (6) Finally, tumor characteristics may induce
oral symptoms directly
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– was able to wear a dental prosthesis (in case of an
edentulous mandible or maxilla, or a partially dentate
mandible or maxilla; yes/no)
– experienced lack of retention of the dental prosthesis
(yes/no)
– experienced a loss of sensory function of the tongue
(yes/no), lips (yes/no), or elsewhere in the mouth (yes/
no)
– experienced a restricted tongue mobility (yes/no), or lip
mobility (yes/no)
– experienced lack of saliva (yes/no)
– experienced an excess of saliva (yes/no)
– experienced pain in the mouth (yes/no)
– experienced other symptoms, and if so, what kind of
symptoms.
These questions were the result of a consensus between
two experts (RPO, oral maxillofacial prosthetist, and JLNR,
oral maxillofacial surgeon oncologist). These experts were
asked to list the most frequently reported oral symptoms of
patients being treated for oral and oropharyngeal cancer.
Additionally, the patient was asked to rank the burden of
their oral symptoms. The three most burdensome oral
symptoms were recorded.
Functional outcome
Functional outcome was assessed by the Mandibular
Function Impairment Questionnaire (MFIQ). This ques-
tionnaire consists of 11 items assessing perceived
difficulties in mandibular function during social activi-
ties, speaking, taking a large bite, chewing hard food,
chewing soft food, work and/or daily activities, drinking,
laughing, chewing resistant food, yawning, and kissing.
Additionally, six items assess perceived difficulties in
mandibular function when eating a hard cookie, eating
meat, eating a raw carrot, eating French bread, eating
peanuts/almonds, and eating an apple. Eating includes
taking a bite, chewing, and swallowing. Possible answers
were: 0, no difficulty; 1, a little difficulty; 2, quite a bit
of difficulty; 3, much difficulty; and 4, very much
difficulty or impossible without help. The scores are
added to give a sum score (range 0–68). A higher score
indicates more perceived mandibular function impair-
ments and a MFIQ score of ‘0’ indicates no impairment
in mandibular functioning. Internal consistency of the
questionnaire ranges between 0.80 and 0.95 [14]. The
outcome of the questionnaire is independent of the method
applied, whether by interview or filled out by the patient
(r=0.95) [14]. The MFIQ has previously been used to
assess mandibular function after treatment of a chronic
closed lock, subacute non-specific temporomandibular
disorders, a painful disc displacement, and to determine
a functional cutoff point for trismus [15–18].
Statistical analysis
Statistical analysis was performed using SPSS 16.0 for
Windows software (SPPS Inc., Chicago, IL, USA). Statis-
tical analysis included univariate analyses and multivariate
linear regression analyses.
In the univariate analyses, associations between MFIQ
scores and possible predictors were analyzed by means of
independent samples t test and Pearson's correlation
coefficient (r).
Possible predictors included age (years), gender (male/
female), dental status (dentate/edentulous), T stage (T1/T2
versus T3/T4), radiotherapy (yes, no), surgery of the
mandible (yes, no), interval between last oncology treat-
ment and time of assessment (years), and oral symptoms:
lack of saliva, restricted mouth opening, reduced tongue
mobility, lack of retention of the prosthesis, reduced
sensation of the lips, inability to wear a prosthesis, reduced
sensation of the tongue, restricted mobility of the lips,
reduced sensation elsewhere in mouth, pain in the mouth,
excessive saliva, and swallowing problems (yes, no).
In the multivariate linear regression analysis, MFIQ
score was used as the outcome variable. Variables related to
MFIQ score in the univariate analyses (p≤0.10) were
entered as predictors (stepwise backward, entry criterion
p≤0.05, removal criterion p>0.10). Interaction effects
between the predictor variables were explored.
Results
One hundred and one patients were asked to participate.
Twelve patients did not fulfill the inclusion criteria or
refused to participate in the study, giving 89 patients (88%)
to participate in the study. Patient characteristics, tumor
type, tumor localization, and treatment received are
summarized in Table 1. Median interval (inter quartile
range) between the last oncology treatment and the time of
assessment was 1.7 years (0.9 to 4.1 years). The mean
MFIQ score was 24.3 (SD 16.9). MFIQ score of radiated
patients (mean 28.9, SD 14.9) was significantly higher than
that of non-radiated patients (mean 16.7, SD 17.6, p=
0.001). Most patients (76%) were treated for a squamous
cell carcinoma, which was most frequently located in the
tongue (36%). Sixty-three percent of the patients were
treated with radiotherapy.
Twenty patients (22%) did not wear their dental
prosthesis during the assessment, of which eight patients
did not wear their upper dentures and 12 patients did not
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upper or lower dentures (Table 2).
The TN classification could be found in the medical
records for 75% of the patients (Table 3). Patients with a
missing TN classification were treated further in the past
(mean 4.4, SD 4.2 years) than patients with a recorded TN
classification (mean 2.8, SD 3.9 years, p=0.138). Patients
with a missing TN classification were also more likely to
have been previously treated in another medical center.
Lack of saliva was the most frequently reported oral
symptom (52%), followed by a restricted mouth opening
(48%) and restricted tongue mobility (46%). Lack of
saliva was ranked as the most burdensome oral symptom
by 32% of patients. Restricted tongue mobility and
restricted mouth opening were ranked equally burden-
some by 14% of patients (Table 4).
A significant interaction between radiotherapy and
restricted mouth opening was found to predict MFIQ
scores. Therefore, the relationship between predictive
variables and MFIQ scores were analyzed separately for
radiated and non-radiated patients. In radiated patients,
age, gender, restricted mouth opening, an inability to
wear a dental prosthesis, surgery of the mandible, being
fully edentulous, and T stage were significantly related to
MFIQ scores (p≤0.10). In non-radiated patients, a
restricted mouth opening, restricted tongue mobility,
reduced sensation elsewhere in mouth (other than tongue
or lip), restricted lip mobility, reduced tongue sensation,
an inability to wear a dental prosthesis, surgery of the
mandible, and being fully edentulous were significantly
r e l a t e dt oM F I Qs c o r e s( p≤0.10). For radiated patients, an
inability to wear a dental prosthesis, T stage (T3/T4), and
Table 1 Characteristics of patients, tumor type, tumor localization,
and tumor treatment
Variables
Age (years) interval between
last oncology treatment and
assessment (years)
Median (inter
quartile range)
1.7 (0.9 to 4.1)
Mean (SD)
61.0 (14.0)
MFIQ score (scoring
range 0 to 68)
24.3 (16.9)
% n
Gender
Male 57 51
Female 43 38
Tumor type
Squamous cell carcinoma 76 68
Salivary gland tumor 18 16
Other 6 5
Tumor localization
a
Tongue 36 32
Alveolar process of the mandible 24 21
Floor of mouth 19 17
Alveolar process of the maxilla 11 10
Salivary gland 11 10
Soft palate 11 10
Lip 10 9
Pharyngeal arch 8 7
Cheek 7 6
Base of the tongue 7 6
Tonsil 5 4
Lateral and dorsal wall of the
oropharynx
22
Buccogingival vault of the maxilla 1 1
Buccogingival vault of the mandible 1 1
Other
b 11
Radiotherapy
Yes 63 56
No 37 33
Surgery of the mandible
Yes 28 25
No 72 64
aN=137. In 67% of the patients, the tumor was located on one site. In the
other patients, the tumor extended over several regions. Therefore, the total
number of localizations exceeded the total number of patients
bNasopharynx
Table 2 Dental status
Dental status Mandible
dentate
Mandible
partially dentate
Mandible
edentulous
Total
Maxilla dentate 13 5 – 18
Maxilla
partially dentate
59 3 1 7
Maxilla
edentulous
– 84 6 5 4
Total 18 22 49 89
Table 3 TN classification on the basis of the pathology report
Status T1 T2 T3 T4 Total
N0 20 13 5 8 46
N 1 21216
N2 1 – ––1
N2b 1 4 1 6 12
N2c –––11
N3 – 1 ––1
Total 24 19 8 16 67
TN classification was present in the medical records of 67 patients
(75%)
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radiated patients, restricted mouth opening, an inability to
wear a dental prosthesis, restricted tongue mobility, and
surgery of the mandible were predictive of higher MFIQ
scores (Table 5).
Discussion
The current study demonstrated that lack of saliva was not only
the most frequently reported oral symptom after treatment for
oral or oropharyngeal cancer, but also the most burdensome,
with almost one third of the patients ranking it highest. This
findinghas beenreportedpreviously[19]. Radiotherapy causes
damage to the salivary glands, resulting in reduced volume
and altered composition of saliva [3]. The consistency of
saliva changes from thin to thick, with a reduced pH and
buffering capacity [3, 19]. In addition to dryness of the mouth
and thirst, lack of saliva may cause an accumulation of mucus,
a burning sensation, taste disturbances, difficulties in oral
functioning, and problems wearing dentures [3].
A restricted mouth opening and restricted tongue
mobility were reported by almost half of the patients.
These oral symptoms were reported among the three most
burdensome. Both symptoms are known to occur frequently
after treatment for oral or oropharyngeal cancer [20, 21].
Despite the fact that lack of saliva was most frequently
mentioned and was ranked most burdensome for many
patients, it was not predictive for functional outcome.
Generally, lack of saliva is perceived as very inconvenient,
however, patients may compensate by using artificial saliva
or by drinking during meals [4, 22]. Most patients prefer
water as a lubricant [3]. It might also be possible that the
influence of lack of saliva on the regression analyses was
obscured by low statistical power.
A mean MFIQ score of 24.3 was found, indicating that
averagely patients experience a substantial amount of
mandibular impairment after treatment of oral and oropha-
ryngeal cancer. The finding that radiated patients had a
poorer functional outcome than non-radiated patients has
been described previously [23]. However, for radiated
patients and non-radiated patients the MFIQ scores were
predicted by different variables. The only common variable
in the regression analyses an inability to wear dental
prosthesis. In non-radiated patients the impact on functional
outcome was slightly larger (β=14.3) than in radiated
patients (β=10.5). Edentulous or partially dentate
patients may not be able to wear a dental prosthesis
because of lack of retention resulting from anatomical
changes post surgery. Pain may also prevent patients
from wearing dentures, resulting in problems with biting
and chewing food [1]. Patients who are fitted with a
dental prosthesis are known to have a better functional
outcome than those who are not fitted with prosthesis,
based on List's Performance Status Scale [10].
In the current study, a higher T stage was associated
with poorer functional outcome. As this relationship was
found only in radiated patients, the T stage may have
acted as a confounding variable. Patients with larger
tumors (T3, T4) generally undergo combined treatment,
this treatment results in greater tissue damage and scar
formation further impeding mandibular function.
In radiated patients, an older age predicted poorer
mandibular function. This relationship might be
explained by normal aging processes and additional
comorbidity, known to be more frequent as age
increases. Comorbidity is negatively associated with
Table 4 Oral symptoms reported by 89 patients treated for oral or
oropharyngeal cancer and ranking of symptoms according to their
perceived burden
Oral
symptoms
Percent n Most
burdening
symptom (n
=88); %
Second
most
burdening
symptom
(n=72); %
Third most
burdening
symptom
(n=56); %
Lack of saliva 52 46 32 11 5
Restricted
mouth
opening
48 42 14 14 18
Reduced
tongue
mobility
46 41 14 24 13
Lack of
retention of
the prosthesis
39 34 9 10 5
Reduced
sensation of
the lips
30 27 6 11 7
Inability to
wear a
prosthesis
28 25 9 7 9
Reduced
sensation of
the tongue
27 24 7 8 13
Restricted
mobility of
the lips
25 22 3 6 9
Reduced
sensation
elsewhere in
the mouth
23 20 5 4 9
Pain in the
mouth
17 15 2 4 5
Excess of
saliva
65 –– –
Swallowing
problems
65 –– –
Some patients reported only the most burdensome oral symptom (n=
88) whereas others also reported the second or third most burdensome
oral symptoms
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vanced oral or oropharyngeal cancer [23]. A restricted
mouth opening was expected to be a strong predictor of
poor mandibular function in radiated patients. However,
a restricted mouth opening appeared to have the largest
effect in non-radiated patients [24]. Nevertheless, re-
stricted mouth opening, as well as restricted tongue
mobility, is well known for negatively affecting oral
functioning [21, 25].
It is clear that an inability to wear a dental prosthesis
greatly impedes mandibular functioning. Therefore,
providing patients, both radiated and non-radiated, with
a dental prosthesis is an important measure to reduce
mandibular impairment. Clinically, the dental prosthesis
should have an optimal retention, although retention
was not a significant factor in the regression analysis.
Additionally, for non-radiated patients, treatment of
restricted mouth opening and restricted tongue mobility
may reduce mandibular impairment.
Rehabilitation of patients after treatment for oral or
oropharyngeal cancer should focus on preserving mouth
opening and tongue mobility. However, preservation of
mouth opening after radiation therapy is difficult. The
average reduction in mouth opening ranges from 18% to
32%, with the greatest decrease occurring between 1
and 9 months after radiotherapy [26, 27]. The currently
frequently applied intensity-modulated radiotherapy
reduces mouth opening less than conventional radiother-
apy [28]. Once mouth opening has decreased, it is
difficult to achieve improvement. The effects of exer-
cises on a restricted mouth opening after oral or
oropharyngeal cancer are limited with in a mean
i n c r e a s eo f5t o6m m[ 29]. TheraBite® treatment seems
to be effective [30]. Restricted tongue mobility may be
improved by speech therapy, including range of motion
exercises [31–33].
Strengths of this study include the use of a
standardized, valid, and reliable questionnaire, and the
assessment of multiple symptoms related to oral and
oropharyngeal cancer. Limitations of the current study
include the relatively small sample size which hampered
statistical analysis, the cross-sectional study design, and
the substantial number of missing data regarding T stage
in the medical records.
More insight into the development of oral symptoms
is needed to determine which should be prevented in
order to maintain mandibular function and achieve
optimal functional outcome.
Conclusions
Lack of saliva is not only the most frequently reported
oral symptom after treatment for oral or oropharyngeal
cancer, but also the most burdensome. Functional
outcome is strongly influenced by an inability to wear
a dental prosthesis in both radiated and non-radiated
patients.
Table 5 Results of multivariate linear regression analyses to predict the score on the MFIQ
MFIQ score (scale range 0–68) β SE 95% CI β Significance of β
Radiated patients
Not being able to wear a dental prosthesis
a 10.5 4.2 2.1 to 18.9 p=0.016
T stage 6.9 4.2 −1.5 to 15.3 p=0.103
Age
b 0.5 0.1 0.2 to 0.8 p<0.001
Constant −7.8 8.5 −24.9 to 9.4 p=0.366
r²=0.45
Non-radiated patients
Restricted mouth opening
a 22.9 3.9 14.9 to 30.9 p<0.001
Not being able to wear a dental prosthesis
a 14.3 4.9 4.4. to 24.3 p=0.006
Restricted tongue mobility
a 13.0 3.8 5.2 to 20.9 p=0.002
Surgery of the mandible
a 12.8 6.3 −0.1 to 25.7 p=0.052
Constant 1.5 2.5 −3.7 to 6.7 p=0.564
r²=0.72
β Regression coefficient, SE standard error of β, 95% CI β 95% confidence interval of the regression coefficient, r² explained variance of the
regression model
aYes=1, no=0
bPer year
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